Abstract:The major targets of current drugs used in mental health, such as neurotransmitter receptors and transporters, are based on serendipitous findings from several decades ago, and there is currently a severe drought of new drug targets. There is a pressing need for novel drugs, and much hope has been placed on the use of molecular genetics to help define them. However, despite evidence for a genetic basis to schizophrenia stretching back for over a century, and a heritability of about 80%, the identification of susceptibility genes has been an uphill struggle. Candidate gene studies, which have generally focussed on obvious candidates from the dopamine and serotonin systems, as well as genes involved in brain development, have not generally been successful, although meta-analysis indicates that the dopamine D3 receptor gene (DRD3) and the serotonin receptor gene type 2A (HTR2A) may have a very small influence on risk. Linkage analysis has provided robust evidence of genetic loci, for example, on chromosomes 8p, 13q and 22q, and also implies shared genetic aetiology with bipolar disorder. The identification of these loci together with advances in genetic technology, especially the characterisation of polymorphisms, the understanding of haplotypes and the development of statistical methods, has lead to the identification of several plausible susceptibility genes, including neuregulin 1, proline dehydrogenase and dysbindin. Interestingly, these genes point more towards a role for the glutamate pathway rather than the dopamine pathway in schizophrenia. We have attempted to replicate some of these findings in schizophrenic patients from SW China, and we find significant association with a novel neuregulin 1 haplotype, with proline dehydrogenase polymorphisms, but not with catechol-O-methyltransferase (COMT). The replication of neuregulin 1 association on chromosome 8p by several investigators is the most convincing to date, and the presence of a syndrome similar to dementia praecox of 8p linked families, and the lack of linkage of bipolar disorder to this region is a testament to the ideas of Kraepelin more than 100 years ago.

The schizophrenia susceptibility gene NAGA regulates dendritic spine density: further evidence for the dendritic spine pathology of schizophrenia

Significant Linkage and Association Between a Functional (gt)n Polymorphism in Promoter of the N-methyl-D-aspartate Receptor Subunit Gene (GRIN2A) and Schizophrenia.

Dendritic spine pathology in neuropsychiatric disorders

Identification of a psychiatric risk gene NISCH at 3p21.1 GWAS locus mediating dendritic spine morphogenesis and cognitive function

Impacts of CACNB4 overexpression on dendritic spine density in both sexes and relevance to schizophrenia

The genetics of schizophrenia: glutamate not dopamine?

Spine impairment in mice high-expressing neuregulin 1 due to LIMK1 activation

A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression

The Schizophrenia Susceptibility Gene OPCML Regulates Spine Maturation and Cognitive Behaviors Through Eph-Cofilin Signaling.

The autism risk gene CNTN4 modulates dendritic spine formation

Structural and biochemical alterations in dendritic spines as key mechanisms for severe mental illnesses

Dendritic spines and their role in the pathogenesis of neurodevelopmental and neurological disorders

Reduction of SynGAP-γ, disrupted splicing of , and oligodendrocyte deficits in mice, a genetic model of schizophrenia and neurodevelopmental disorder

Schizophrenia risk gene ZNF804A controls ribosome localization and synaptogenesis in developing human neurons

Dendritic structural plasticity and neuropsychiatric disease

Eps8 controls dendritic spine density and synaptic plasticity through its actin-capping activity

Impact of dendritic spine loss on excitability of hippocampal CA1 pyramidal neurons: a computational study of early Alzheimer disease

Regional differences in dendritic spine density confer resilience to chronic social defeat stress

Loss of neuronal GSK3β reduces dendritic spine stability and attenuates excitatory synaptic transmission via β-catenin

Protracted dendritic growth in the typically developing human amygdala and increased spine density in young ASD brains

Neurone specific regulation of dendritic spines in vivo by post synaptic density 95 protein (PSD-95)